These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6995325)

  • 1. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):881-6. PubMed ID: 6995325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.
    Yarkoni E; Rapp HJ
    Cancer Res; 1979 May; 39(5):1518-20. PubMed ID: 427795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of surfactant concentration on the antitumor activity of emulsified components of mycobacteria.
    Yarkoni E; Rapp HJ
    Cancer Res; 1980 Apr; 40(4):975-8. PubMed ID: 7357563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria.
    Yarkoni E; Rapp HJ
    Cancer Res; 1979 Feb; 39(2 Pt 1):535-7. PubMed ID: 761228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of oil and Tween concentrations on enhanced endotoxin lethality in mice pretreated with emulsified trehalose-6,6'-dimycolate (cord factor).
    Yarkoni E; Rapp HJ
    Infect Immun; 1979 May; 24(2):571-2. PubMed ID: 378860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
    Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
    Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):887-92. PubMed ID: 6995326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
    Yarkoni E; Rapp HJ
    Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of BCG cell-wall skeletons (BCG-CWS) emulsified in squalane on tumor growth and metastasis in mice.
    Yoo YC; Hata K; Lee KB; Azuma I
    Arch Pharm Res; 2002 Aug; 25(4):522-7. PubMed ID: 12214866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.
    Yarkoni E; Lederer E; Rapp HJ
    Infect Immun; 1981 Apr; 32(1):273-6. PubMed ID: 7216489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    Zbar B; Rapp HJ; Ribi EE
    J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
    Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
    Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls.
    Yarkoni E; Rapp HJ
    Infect Immun; 1979 Sep; 25(3):1087-9. PubMed ID: 387592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of microscopic hepatic metastases by active specific immunization.
    Sukumar S; Hunter JT; Terata N; Rapp HJ
    Cancer Immunol Immunother; 1983; 14(3):151-4. PubMed ID: 6340824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
    McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
    Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy.
    Granger DL; Brehmer W; Brehmer W; Yamamoto K; Ribi E
    Infect Immun; 1976 Feb; 13(2):543-53. PubMed ID: 770333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of cotton rats against experimental Echinococcus multilocularis infections with BCG cell walls.
    Reuben JM; Tanner CE; Portelance V
    Infect Immun; 1979 Mar; 23(3):582-6. PubMed ID: 378829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
    Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
    Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.
    Yarkoni E; Rapp HJ
    Infect Immun; 1981 Jan; 31(1):514-6. PubMed ID: 7216457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.